Literature DB >> 1916851

Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media.

A B Lang1, U Schuerch, S J Cryz.   

Abstract

To facilitate the production and purification of human monoclonal antibodies, we evaluated the ability of human hybridomas to adapt to chemically defined-serum free media. From a panel of human hybridomas secreting antibody against serotype specific lipopolysaccharide determinants of gram-negative bacteria, the growth and secretion properties of the two hybridomas producing antibodies against two strains of Pseudomonas aeruginosa, 4-8KH15 and 4-10KH139, were analysed. Both clones did not grow in protein-free medium. However, it was possible to adapt them to serum-free media consisting of a basal medium supplemented with insulin, transferrin, ethanolamine, and selenite. Antibody secretion rates were equal (4-8KH15: 26-31 micrograms IgM/10(6) cells/day) or higher (4-10KH139: 58-90 micrograms IgM/10(6) cells/day) in serum-free media as compared to conventional serum-supplemented medium. Our studies suggest that adaptation of the described hybridomas to selected serum-free media results in an antibody production which is very high as compared with reports in comparable systems. The establishment of these conditions will significantly facilitate the production of large amounts of human monoclonal antibodies which is a prerequisite for a therapeutical application.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916851     DOI: 10.1089/hyb.1991.10.401

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  6 in total

1.  Scale-up and optimization of culture conditions of a human heterohybridoma producing serotype-specific antibodies to Pseudomonas aeruginosa.

Authors:  U Schürch; S J Cryz; A B Lang
Journal:  Appl Microbiol Biotechnol       Date:  1992-07       Impact factor: 4.813

2.  Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of BALB/c mice.

Authors:  Fatemeh Ezzatifar; Jafar Majidi; Behzad Baradaran; Leili Aghebati Maleki; Jalal Abdolalizadeh; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice.

Authors:  Leili Aghebati Maleki; Jafar Majidi; Behzad Baradaran; Jalal Abdolalizadeh; Tohid Kazemi; Ali Aghebati Maleki; Koushan Sineh Sepehr
Journal:  Adv Pharm Bull       Date:  2013-02-07

4.  Mass-Production and Characterization of Anti-CD20 Monoclonal Antibody in Peritoneum of Balb/c Mice.

Authors:  Koushan Sineh Sepehr; Behzad Baradaran; Jafar Majidi; Jalal Abdolalizadeh; Leili Aghebati; Fatemeh Zare Shahneh
Journal:  Adv Pharm Bull       Date:  2013-02-07

5.  A unique report: development of super anti-human IgG monoclone with optical density over than 3.

Authors:  Leili Aghebati Maleki; Behzad Baradaran; Jalal Abdolalizadeh; Fatemeh Ezzatifar; Jafar Majidi
Journal:  Adv Pharm Bull       Date:  2013-08-20

6.  Enhancement of the attachment on microcarriers and tPA production by fibroblast cells in a serum-free medium by the addition of the extracts of Centella asiatica.

Authors:  Y N Kim; Y S Park; H K Kim; B C Jeon; S E Youn; H Y Lee
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.